{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:30:16Z","timestamp":1790206216883,"version":"4.1.0"},"reference-count":4,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.1093\/jac\/dkaa341","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T19:12:44Z","timestamp":1600110764000},"page":"3699-3700","source":"Crossref","is-referenced-by-count":4,"title":["Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study\u2014authors\u2019 response"],"prefix":"10.1093","volume":"75","author":[{"given":"Christine","family":"Katlama","sequence":"first","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris (APHP), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Service des Maladies Infectieuses et Tropicales, Paris, France"},{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique (IPLESP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambert","family":"Assoumou","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique (IPLESP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Antoine","family":"Valantin","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris (APHP), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Service des Maladies Infectieuses et Tropicales, Paris, France"},{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique (IPLESP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathia","family":"Souli\u00e9","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique (IPLESP), Paris, France"},{"name":"APHP, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Laboratoire de virologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Martinez","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Hospital Clinic and University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"B\u00e9niguel","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique (IPLESP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bouchaud","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris (APHP), Centre Hospitalier Universitaire Avicenne, Service des Maladies Infectieuses et Tropicales, Bobigny, France"},{"name":"Universit\u00e9 Paris 13, IMEA-Fondation Internationale L\u00e9on Mba, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Raffi","sequence":"additional","affiliation":[{"name":"INSERM CIC 1413, Universit\u00e9 de Nantes, D\u00e9partement des Maladies Infectieuses, H\u00f4pital H\u00f4tel-Dieu, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Molina","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Diderot, Paris, France, Sorbonne Paris Cit\u00e9, APHP, H\u00f4pital Saint-Louis, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Fellahi","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM UMRS_938, Institut Hospitalo-Universitaire de Cardio-m\u00e9tabolisme et Nutrition (ICAN), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4359-537X","authenticated-orcid":false,"given":"Gilles","family":"Peytavin","sequence":"additional","affiliation":[{"name":"INSERM UMR 1137, Universit\u00e9 Paris 7, Laboratoire de Pharmacologie-Toxicologie, H\u00f4pital Bichat-Claude Bernard, APHP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Genevi\u00e8ve","family":"Marcelin","sequence":"additional","affiliation":[{"name":"APHP, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Laboratoire de virologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Kolta","sequence":"additional","affiliation":[{"name":"D\u00e9partement de rhumatologie, H\u00f4pital Cochin, Paris, France - INSERM UMR-1153, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Capeau","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM UMRS_938, Institut Hospitalo-Universitaire de Cardio-m\u00e9tabolisme et Nutrition (ICAN), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Gibowski","sequence":"additional","affiliation":[{"name":"ANRS, France Recherche Nord & Sud Sida-Hiv H\u00e9patites, Agence autonome de l\u2019INSERM, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Cardon","sequence":"additional","affiliation":[{"name":"ANRS, France Recherche Nord & Sud Sida-Hiv H\u00e9patites, Agence autonome de l\u2019INSERM, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Reynes","sequence":"additional","affiliation":[{"name":"D\u00e9partement de maladies infectieuses, UMI 233 INSERM U1175, CHU de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique (IPLESP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"key":"2020111305063360200_dkaa341-B1","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkaa120","article-title":"Comment on: Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study","author":"Del Puente","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2020111305063360200_dkaa341-B2","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1093\/jac\/dkz224","article-title":"Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study","volume":"74","author":"Katlama","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2020111305063360200_dkaa341-B3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/23744235.2019.1569257","article-title":"Is it time to re-think the use of etravirine in patients with available genotypic resistance test?","volume":"51","author":"Del Puente","year":"2019","journal-title":"Infect Dis (Lond)"},{"key":"2020111305063360200_dkaa341-B4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(17)33095-7","article-title":"Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies","volume":"391","author":"Llibre","year":"2018","journal-title":"Lancet"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/12\/3699\/34291423\/dkaa341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/12\/3699\/34291423\/dkaa341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T10:07:15Z","timestamp":1605262035000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/75\/12\/3699\/5909211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":4,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,9,20]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa341","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2019,9,20]]}}}